Christopher Visit 2: 54-year-old male with family history of diabetes and elevated A1C, 3-month follow-up

Curriculum:
N/A
Credits:
0.5 AMA PRA Category 1 Credits
Launch Date:
08-Feb-10
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No Primary Audience Was Provided.

Relevant Terms:

No Primary Audience Was Provided.

Om P. Ganda, MD

Om P. Ganda, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Director, Lipid Clinic
Joslin Diabetes Center
Boston, MA

Dr. Ganda is a Senior Physician, Director of the Lipid Clinic, and Chairman of the Clinical Oversight Committee at the Joslin Diabetes Center, and Associate Clinical Professor of Medicine at Harvard Medical School in Boston, Massachusetts.

Dr. Ganda has been a co-investigator for several National Institutes of Health (NIH) studies, including the Diabetes Control and Complications Trial (DCCT) and the Diabetes Prevention Program (DPP). He is currently a co-investigator for the NIH Epidemiology of Diabetes Interventions and Complications (EDIC) study. He is also participating in clinical trials related to lipid-lowering drugs and diabetes management.

Dr. Ganda has written more than 110 publications including 45 original articles, 35 review articles, and 25 book chapters.

Dr. Ganda is an Associate Editor of Endocrine Practice and serves on the editorial board of Diabetes Research and Clinical Practice. He is an ad hoc reviewer for several journals including Diabetes, Diabetes Care, The Journal of Clinical Endocrinology and Metabolism, JAMA, and The New England Journal of Medicine. He is an invited reviewer for the scientific abstracts for the annual ADA meetings.

Bernard Zinman, MD, MDCM, FACP, FRCP

Bernard Zinman, MD, MDCM, FACP, FRCP
Professor of Medicine
University of Toronto
Director, Leadership Sinai Centre for Diabetes
Mount Sinai Hospital
Toronto, Ontario, Canada

Dr. Zinman is Director of the Leadership Sinai Centre for Diabetes and holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and the University of Toronto, Canada. He is Professor of Medicine at the University of Toronto and Senior Scientist at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Dr. Zinman was Director of the Banting and Best Diabetes Centre (1993-2000) and is involved with diabetes care and research at both national and international levels. Dr. Zinman is Principal Investigator of the University of Toronto Centre and Vice-Chair of the DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) study.

Dr. Zinman graduated MDCM from McGill University in Montreal, where he also received his postgraduate training in internal medicine. He undertook further training in Endocrinology at the University of Toronto.

Dr. Zinman has written more than 300 publications in national and international journals, and over 60 book chapters and editorials. He is the recipient of numerous awards including the Charles H. Best Medal for Distinguished Service in the Cause of Diabetes (awarded to the DCCT Investigators), the Alois Beringer Lecture Award, the Frederick G. Banting Award, and the Gerald S. Wong Service Award of the Canadian Diabetes Association (CDA). In November 2000, Dr. Zinman chaired the scientific program committee of the 17th International Diabetes Federation Congress held in Mexico City. In August 2003, Dr. Zinman delivered the Banting and Best Memorial Lecture at the International Diabetes Federation Congress in Paris, France. In 2006 Dr. Zinman received the American Diabetes Associations Outstanding Physician Clinician Award.

His main research interests include the long-term complications of diabetes mellitus, the development of new therapies for type 1 and type 2 diabetes, diabetes in Aboriginal communities, and studies directed at the prevention of diabetes.

Paul S. Jellinger, MD, MACE

Paul S. Jellinger, MD, MACE
Professor of Medicine, Voluntary Faculty
University of Miami
Past President
American College of Endocrinology
American Association of Clinical Endocrinologists
Miami, FL

Dr. Jellinger is Past President of the American Association of Clinical Endocrinologists (AACE) and Past President of the American College of Endocrinology (ACE). He is Professor of Medicine on the voluntary faculty at the University of Miami. In May 2004, he became a Master of the American College of Endocrinology (MACE).

After receiving his medical degree from Wayne State University School of Medicine, Dr. Jellinger completed a first-year medical residency at Beth Israel Hospital and a second-year residency at Mount Sinai Hospital in New York City. He subsequently was awarded an NIH fellowship in Endocrinology at Mount Sinai Hospital. Dr. Jellinger has served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. He is involved in many regional and national professional and scientific associations including The Endocrine Society and the American Diabetes Association and is Past President of The Florida Endocrine Society. Dr. Jellinger is board-certified in internal medicine and endocrinology and metabolism. He has also conducted investigative research on over 50 subjects and is currently conducting research for several major pharmaceutical companies. Dr. Jellinger currently serves as Medical Editor of Clinical Endocrinology News.

Dr. Jellinger, who was a founding member, was elected President of the American Association of Clinical Endocrinologists, a 5500-physician member organization, in May 2000. He has been active on the AACE Board of Directors and has served as chairman of several committees including the Clinical Research Committee. Dr. Jellinger was also a member of the task forces that defined and published the AACE Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus, AACE Medical Guidelines for Clinical Practice for Evaluation and Treatment of Hyperthyroidism and Hypothyroidism, and the AACE Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. He served as Chairman of the Task Force for the AACE Medical Guidelines for Clinical Practice for Diagnosis and Treatment of Dyslipidemia and Prevention of Atherogenesis. He was a participant in both the 2001 and 2002 ACE/AACE Consensus Conferences on Glycemic Control and the Insulin Resistance Syndrome and was Co-Chairman of the 2005 ACE/AACE Diabetes Consensus Conference on Implementation of Glycemic Goals. He is co-author of the recently published ACE/AACE Roadmap for the Prevention and Treatment of Type 2 Diabetes and was a contributing author to the recently published ACE/AACE Guidelines for the Treatment of Diabetes Mellitus. He served as a Task Force and Writing Committee member of the recently published 2008 Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia-When Do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists and is Co-Chair of the ACE/AACE Diabetes Treatment Algorithm Task Force. Dr. Jellinger lectures frequently on topics related to diabetes mellitus and lipid disorders.
1. Identify key practice and type 2 diabetes management issues at the core of consultative treatment interactions between specialty and primary care practices
2. Describe evidence-based recommendations regarding treatment goals and methods of therapy addressed by type 2 diabetes treatment guidelines
3. Assess educational needs of primary care providers and specialist support gaps based on an evaluation of consultative referrals
4. Utilize evaluation described above to design and implement improved systems for enhancing the efficacy and efficiency of consultative interactions related to diabetes management